1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with aglafoline in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (aglafoline) | Trials (aglafoline) | Recent Studies (post-2010) (aglafoline) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 13 | 0 | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, TF; Ko, FN; Liou, MJ; Teng, CM; Wu, TS | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and aglafoline
Article | Year |
---|---|
PAF antagonism in vitro and in vivo by aglafoline from Aglaia elliptifolia Merr.
Topics: Adenosine Triphosphate; Animals; Benzofurans; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Humans; In Vitro Techniques; Male; Phosphatidylinositols; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Rats; Rats, Inbred Strains; Thromboxane B2 | 1992 |